Your Current Location : Fund Card : Portfolio Classification |
|
|
|
Nippon India Nifty Pharma ETF |
[Equity: Index] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Current Asset |
-0.01 |
Equity |
99.78 |
Trep |
0.23 |
|
|
Concentration Analysis |
Top 5 Holdings |
63.01% |
Top 10 Holdings |
81.59% |
Top 25 Holdings |
100.00% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
99.78 |
Cash |
0.22 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
4.83 |
PE Ratio |
35.22 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
Sun Pharmaceutical Industries Limited |
26.80 |
Cipla Limited |
12.03 |
Dr Reddys Laboratories Limited |
11.48 |
DIVI LABORATORIES LTD |
6.72 |
Lupin Limited |
5.98 |
Aurobindo Pharma Limited |
4.69 |
Zydus Lifesciences Limited |
3.90 |
Alkem Laboratories Limited |
3.80 |
Torrent Pharmaceuticals Limited |
3.64 |
IPCA Laboratories Limited |
2.55 |
MANKIND PHARMA LIMITED |
2.54 |
Laurus Labs Limited |
2.36 |
Abbott India Limited |
2.21 |
Glenmark Pharmaceuticals Limited |
2.20 |
Gland Pharma Limited |
1.95 |
Biocon Limited |
1.80 |
J B Chemicals and Pharma Limited |
1.80 |
Natco Pharma Limited |
1.32 |
Sanofi India Limited |
1.12 |
Granules India Limited |
0.89 |
Triparty Repo |
0.23 |
Net Current Assets |
-0.01 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
|
|
|
|
|